Chicago,
Illinois--August 25, 2008--InfrAegis announced today on behalf of Bacteria
Sciences Worldwide, LLC (BSW) that DLM Capital Investors, LLC (DLM) is investing
$1 billion in BSW for 30% of the Company. DLM will receive one BSW board seat.
Don Morrow, President and CEO of DLM said, “I really believe in BSW and its
ability to deal with significant common problems like food safety, and their
harmful bacteria identification capability. I believe BSWs innovative products
will aide in potentially protecting us from the affects of radiation poisoning,
from the affects of dirty bombs, and from the affects of ultra-violet A, B, & C
caused by the thinning of the ozone layer”. Michelle Butler, Chief Operating
Officer of DLM, stated, “BSW has an exciting future. We want to be a part of it
and we want to serve mankind”. InfrAegis welcomes “the DLM team”, their
financial support, and their belief in the BSW teams’ scientists and management.
DLM, The Company of Entrepreneurs, is a U.S. firm operating on a global scale to
develop, enhance, and support communities by creating, overseeing, and investing
in projects and programs dealing with today's most troublesome issues. DLM
strives to create jobs, provide liquidity in the US market, and develop
cutting-edge solutions by providing the necessary capital. For more information
visit: www.dlm-ci.com.
BSW offers exciting products and services that provide
for food safety, improve health and promote Human Continuity™. Please see our
website at www.ia-bsw.com. Our Molecular Microbial DNA Detection System created
by Dr. Robert Levin rapidly identifies harmful bacteria like E.coli 0157 H:7,
Salmonella and others. BSWs’ Gamma NutraceuticalsTM platform created by Dr.
Kalidas Shetty, seeks to protect mankind, animals, fish, fowl, seeds, and plants
from the destructive effects from ultra-violet A, B, and C radiation poisoning
that may cause skin cancers, dysentery, and damage to the eyes. The C3
anti-microbial sanitizers hold promise in combating MRSA, Staph, E.Coli 0157
H:7, and other harmful bacteria and viruses. “We are very pleased with the
progress that the company has made” said Gregory E. Webb, Chairman of the Board
and Chief Executive Officer.
Please visit
www.ia911.com for all the exciting
products and services provided by InfrAegis Inc. BSW has licensed certain
patents and intellectual property from InfrAegis. InfrAegis provides management
and financial services to BSW.
This announcement contains historical and
forward-looking information. There are significant risks and uncertainties about
the markets that both InfrAegis and BSW are entering. Execution of the
strategies will be difficult and unpredictable given there are no analogs to
InfrAegis’ and or BSWs’ products, product platforms and services. BSW is
targeting initial product delivery will be approximately 9 to 12 months. Kits
for the Molecular Microbial DNA Detection System are available now and target
delivery for modular kits will be in approximately 4 months. Target delivery of
the fully automated and integrated solution sets is in approximately 9 months.
For Company information on InfrAegis or BSW please contact:
Marie Diffley
(mdiffley@ia911.com) or Robert Langlois (rlanglois@ia911.com) at 1-847-593-0093
InfrAegis, Inc is a security technology and media distribution company that provides products, solutions, and countermeasures to protect and defend borders, ports, mass transit systems, airports, financial institution systems, and critical infrastructure against acts of terrorism. Established in 2003, InfrAegis is highly regarded for its ability to implement leading-edge technology to detect, analyze and monitor weapons of mass destruction and hazardous/contraband materials. The company is dedicated to applying predesignated countermeasures during emergency situations to save lives, protect assets, and mitigate damage. InfrAegis is based in Chicago, IL, with offices in Washington DC, and affiliated offices in Athens, Madrid, Mexico City, and Singapore.
This press release contains forward-looking statements about InfrAegis, Inc. that involve risks and uncertainties. These statements are developed by combining currently available information with InfrAegis’ beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because InfrAegis cannot predict all of the risks and uncertainties that may affect it, nor control the ones it does predict, InfrAegis’ actual results may be materially different from the results expressed in its forward-looking statements.
You can learn more about InfrAegis, Inc. at www.ia911.com.
Return to index of press releases